These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18765403)

  • 41. Correlation between dosimetric effect and intrafraction motion during prostate treatments delivered with helical tomotherapy.
    Langen KM; Lu W; Ngwa W; Willoughby TR; Chauhan B; Meeks SL; Kupelian PA; Olivera G
    Phys Med Biol; 2008 Dec; 53(24):7073-86. PubMed ID: 19015580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Dose Verification System (DVS) for cancer patients receiving radiation therapy.
    Scarantino CW; Beyer GP
    Expert Rev Med Devices; 2008 Nov; 5(6):679-85. PubMed ID: 19025343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
    Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
    Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Calibration of dosimeters with solid-state detectors].
    Astakhova IV; Shirmer EV
    Med Radiol (Mosk); 1974 Apr; 19(4):80-3. PubMed ID: 4461954
    [No Abstract]   [Full Text] [Related]  

  • 45. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.
    Toye W; Das R; Kron T; Franich R; Johnston P; Duchesne G
    Radiother Oncol; 2009 May; 91(2):243-8. PubMed ID: 18954914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of in vivo radiotherapy dosimetry.
    Edwards CR; Mountford PJ
    Br J Radiol; 2009 Nov; 82(983):881-3. PubMed ID: 19752169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
    Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose reconstruction for intensity-modulated radiation therapy using a non-iterative method and portal dose image.
    Yeo IJ; Jung JW; Chew M; Kim JO; Wang B; Dibiase S; Zhu Y; Lee D
    Phys Med Biol; 2009 Sep; 54(17):5223-36. PubMed ID: 19671973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of conformal and intensity modulated treatment planning techniques for early prostate cancer.
    Vaarkamp J; Malde R; Dixit S; Hamilton CS
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):310-7. PubMed ID: 19624299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using total-variation regularization for intensity modulated radiation therapy inverse planning with field-specific numbers of segments.
    Zhu L; Lee L; Ma Y; Ye Y; Mazzeo R; Xing L
    Phys Med Biol; 2008 Dec; 53(23):6653-72. PubMed ID: 18997262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Internal audit of a comprehensive IMRT program for prostate cancer: a model for centers in developing countries?
    Koh WY; Ren W; Mukherjee RK; Chung HT
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1447-54. PubMed ID: 19250761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
    Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
    Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Point/Counterpoint. Noncoplanar beams improve dosimetry quality for extracranial intensity modulated radiotherapy and should be used more extensively.
    Sheng K; Shepard DM; Orton CG
    Med Phys; 2015 Feb; 42(2):531-3. PubMed ID: 25652473
    [No Abstract]   [Full Text] [Related]  

  • 55. Dosimetric verification of RapidArc treatment delivery.
    Korreman S; Medin J; Kjaer-Kristoffersen F
    Acta Oncol; 2009; 48(2):185-91. PubMed ID: 18777411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiothermolumiscent dosimetry in plesioroentgenotherapy].
    Laconi A; Caffarelli F; Melfi F; Brancato G; Polizzi P; Guarino P
    Minerva Med; 1976 Apr; 67(20):1320-4. PubMed ID: 934487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dosimetric study of inverse-planed intensity modulated, forward-planned intensity modulated and conventional tangential techniques in breast conserving radiotherapy.
    Rongsriyam K; Rojpornpradit P; Lertbutsayanukul C; Sanghangthum T; Oonsiri S
    J Med Assoc Thai; 2008 Oct; 91(10):1571-82. PubMed ID: 18972902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LVR-15 reactor epithermal neutron beam parameters--results of measurements.
    Burian J; Klupak V; Marek M; Rejchrt J; Viererbl L; Gambarini G; Bartesaghi G
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S202-5. PubMed ID: 19375340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thermoluminescence dosimetry in patients (author's transl)].
    Möller P; Fehrentz D
    Biomed Tech (Berl); 1980 Jun; 25(6):144-7. PubMed ID: 7448308
    [No Abstract]   [Full Text] [Related]  

  • 60. In vivo dosimetry using a linear Mosfet-array dosimeter to determine the urethra dose in 125I permanent prostate implants.
    Bloemen-van Gurp EJ; Murrer LH; Haanstra BK; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):314-21. PubMed ID: 19100925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.